Tempest Therapeutics Inc. Gains 28.52%
Tue, Apr 11, 2023 at 07:11 PM
Tempest Therapeutics Inc. (TPST:NASDAQ) soared at $3.47, a gain of 28.5%. On Tue, Apr 11, 2023, TPST:NASDAQ touched a New 2-Week High of $3.47. The stock appeared on our News Catalysts scanner on Wed, Mar 22, 2023 at 06:58 PM in the 'INVESTOR UPDATE' category. From Tue, Mar 28, 2023, the stock recorded 77.78% Up Days and 70.00% Green Days
About Tempest Therapeutics Inc. (TPST:NASDAQ)
Tempest Therapeutics Inc is a clinical-stage biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific...
Top 10 Gainers:
- Innovative Eyewear Inc. (LUCY:NASDAQ), 201.37%
- Brenmiller Energy Ltd (BNRG:NASDAQ), 74.07%
- WW International, Inc. (WW:NASDAQ), 58.98%
- National CineMedia, Inc. (NCMI:NASDAQ), 54.96%
- IMAC Holdings Inc. (BACK:NASDAQ), 50.04%
- Alpine Summit Energy Partners Inc. (ALPS:NASDAQ), 49.17%
- Brookdale Senior Living Inc. (BKD:NYSE), 32.55%
- Avalo Therapeutics Inc. (AVTX:NASDAQ), 30.25%
- Brookdale Senior Living Inc. 7.00% Tangible Equity Units (BKDT:NYSE), 29.3%
- Tempest Therapeutics Inc. (TPST:NASDAQ), 28.52%